Cancer patients less protected after first COVID vaccine jab, UK study finds
Cancer patients are much less protected against Covid-19 than other people after one dose of the Pfizer vaccine, the first real-world study in this area suggests.
Share Via Email
| A+A A- By PTI
LONDON: Cancer patients may not be protected to the same degree as the rest of the population after they receive their first of two doses of a COVID-19 vaccine, a new UK study has found on Thursday.
A team of experts from King s College London and Francis Crick Institute found in the first real-world study of its kind that a shorter than the stipulated 12-week gap between the two vaccine doses for such patients appeared to be the answer.
Updated Mar 05, 2021 | 13:26 IST
There is good news for students planning to study in UK. The new post-study graduate route would be opened for international students, including from India from July this year. New UK post-study graduate route to open in July | Photo Credit: iStock Images
The British High Commission on Thursday confirmed the new Graduate route will open for applications from July onwards to international students, including those from India, who successfully complete a degree at undergraduate level or above in the UK.
The British High Commission in a release said international students on the Graduate route will be able to work or look for work after their studies for a maximum period of two years (three years for PhD students). This will help allow the brightest and the best students from India to continue to contribute to the UK post-study.
"These findings show encouraging signs infections are now heading in the right direction across the country, but we must not drop our guard," said UK Health Secretary Matt Hancock.
Seeking Protection From Coronavirus? UK Scientists Develop Anti-Covid Nasal Spray To Keep Virus At Bay
One of the researchers believes that the spray’s formula will help unlock society from social distancing restrictions and get schools going again . Pixabay Outlook Web Bureau 2021-01-24T18:00:48+05:30 Seeking Protection From Coronavirus? UK Scientists Develop Anti-Covid Nasal Spray To Keep Virus At Bay outlookindia.com 2021-01-24T19:42:00+05:30
A nasal spray that can prevent chances of contracting coronavirus for two days is in development at the University of Birmingham and is expected to be available in pharmacies in the next few months, according to The Sunday Telegraph.